Surgery Partners, Inc. (SGRY)
NASDAQ: SGRY · IEX Real-Time Price · USD
25.38
+1.34 (5.57%)
At close: Apr 23, 2024, 4:00 PM
24.34
-1.04 (-4.10%)
After-hours: Apr 23, 2024, 6:45 PM EDT
Surgery Partners Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Surgery Partners stock have an average target of 44.44, with a low estimate of 35 and a high estimate of 51. The average target predicts an increase of 75.10% from the current stock price of 25.38.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for SGRY stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 5 | 5 | 5 | 4 | 4 | 4 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $43 | Buy | Reiterates | $43 | +69.42% | Apr 10, 2024 |
| Barclays | Barclays | Hold Initiates $35 | Hold | Initiates | $35 | +37.90% | Mar 6, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $43 | Buy | Reiterates | $43 | +69.42% | Mar 5, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $49 | Buy | Reiterates | $49 | +93.07% | Feb 29, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $43 → $42 | Strong Buy | Maintains | $43 → $42 | +65.48% | Feb 27, 2024 |
Financial Forecast
Revenue This Year
3.07B
from 2.74B
Increased by 11.76%
Revenue Next Year
3.34B
from 3.07B
Increased by 8.81%
EPS This Year
1.02
from -0.09
EPS Next Year
1.31
from 1.02
Increased by 28.55%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 3.2B | 3.5B | 3.8B |
| Avg | 3.1B | 3.3B | 3.6B |
| Low | 2.9B | 3.2B | 3.4B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 15.5% | 13.8% | 14.2% |
| Avg | 11.8% | 8.8% | 9.1% |
| Low | 7.0% | 3.5% | 2.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 1.18 | 1.56 | 1.80 |
| Avg | 1.02 | 1.31 | 1.65 |
| Low | 0.76 | 1.14 | 1.49 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | 54.1% | 37.5% |
| Avg | - | 28.6% | 26.1% |
| Low | - | 11.9% | 13.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.